TNF and cancer: IL-1β, IL-6, and tumor necrosis factor alpha (TNF-α) can be used as biomarkers of inflammation during radiotherapy and chemoradiotherapy, and their role in head and neck cancer treatment needs to be better explored as pro-inflammatory cytokines activated by radiotherapy may increase the symptoms of cancer treatment (10, 11).